mifepristone has been researched along with cetylpyridinium chloride anhydrous in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 6 (85.71) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furedi, A | 1 |
7 other study(ies) available for mifepristone and cetylpyridinium chloride anhydrous
Article | Year |
---|---|
[Order of 10 September 1992 on the possession, distribution, dispensing, and administration of the pharmaceutical speciality Mifegyne 200 mg. in tablet form].
Topics: Abortion, Induced; Ambulatory Care Facilities; Biology; Delivery of Health Care; Developed Countries; Drug Prescriptions; Economics; Electronic Data Processing; Endocrine System; Europe; Family Planning Services; France; Health; Health Facilities; Health Planning; Hormone Antagonists; Hormones; Legislation as Topic; Marketing of Health Services; Mifepristone; Organization and Administration; Pharmacies; Physiology; Records | 1992 |
USA President Clinton acts to ensure reproductive health.
Topics: Abortion, Induced; Administrative Personnel; Ambulatory Care Facilities; Americas; Biology; Catholicism; Christianity; Counseling; Developed Countries; Developing Countries; Endocrine System; Extraembryonic Membranes; Family Planning Policy; Family Planning Services; Fetus; Government; Government Agencies; Health; Health Planning; Hormone Antagonists; Hormones; Human Rights; International Agencies; Latin America; Legislation as Topic; Mexico; Mifepristone; North America; Organization and Administration; Organizations; Physiology; Pregnancy; Public Policy; Religion; Reproduction; Reproductive Medicine; Research; United States | 1993 |
Comment.
Topics: Abortifacient Agents; Abortion, Induced; Ambulatory Care Facilities; Biology; Delivery of Health Care; Developed Countries; Endocrine System; England; Europe; Family Planning Services; Health; Health Facilities; Health Services Accessibility; Hormone Antagonists; Hormones; Mifepristone; Physiology; Program Evaluation; United Kingdom | 1994 |
Order on the possession, distribution, dispensing, and administration of the pharmaceutical specialty Mifegyne 200 mg. in tablet form, 28 December 1988.
Topics: Abortion, Induced; Biology; Delivery of Health Care; Developed Countries; Drug Prescriptions; Economics; Electronic Data Processing; Endocrine System; Europe; Family Planning Services; France; Health; Health Personnel; Health Planning; Hormone Antagonists; Hormones; Legislation as Topic; Marketing of Health Services; Mifepristone; Organization and Administration; Pharmacists; Physiology; Records | 1988 |
President Clinton reelected with mandate for choice.
Topics: Abortion, Induced; Administrative Personnel; Americas; Biology; Developed Countries; Endocrine System; Evaluation Studies as Topic; Family Planning Services; Government; Health; Hormone Antagonists; Hormones; Human Rights; Legislation as Topic; Mifepristone; North America; Organization and Administration; Physiology; Reproductive Medicine; United States | 1996 |
Abortion.
Topics: Abortion, Induced; Ambulatory Care Facilities; Americas; Biology; Consumer Product Safety; Delivery of Health Care; Developed Countries; Economics; Endocrine System; Extraembryonic Membranes; Family Planning Services; Fetus; Financial Management; Financing, Government; Health; Health Facilities; Hormone Antagonists; Hormones; Human Rights; Individuality; Informed Consent; Insurance, Health; Legislation as Topic; Licensure; Mifepristone; North America; Physiology; Pregnancy; Reproduction; Research; Third-Party Consent; United States | 1992 |
Options expand in wait for mifepristone arrival.
Topics: Abortion, Induced; Americas; Biology; Delivery of Health Care; Developed Countries; Endocrine System; Family Planning Services; Health; Health Personnel; Hormone Antagonists; Hormones; Mifepristone; North America; Physicians; Physiology; United States; Vacuum Curettage | 1998 |